{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:44:32Z","timestamp":1793058272918,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Child Injury Prevention Alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s13181-024-01053-6","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T15:06:16Z","timestamp":1735225576000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tianeptine Exposures Reported to United States Poison Centers, 2015\u20132023"],"prefix":"10.1007","volume":"21","author":[{"given":"Mustafa","family":"Quadir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie I.","family":"Rine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaahnavi","family":"Badeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole L.","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5838-8982","authenticated-orcid":false,"given":"Gary A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"1053_CR1","unstructured":"U.S. Food and Drug Administration. Tianeptine in dietary supplements. [Internet]. U.S. Food and Drug Administration; 2023 [cited 2024 Jun 20]. https:\/\/www.fda.gov\/food\/information-select-dietary-supplement-ingredients-and-other-substances\/tianeptine-dietary-supplements"},{"key":"1053_CR2","unstructured":"Hoffman J. \u2018Gas-Station Heroin\u2019 sold as dietary supplement alarms health officials. [Internet]. New York Times (Digital Edition); 2024 [cited 2024 Jun 1]. https:\/\/www.nytimes.com\/2024\/01\/10\/health\/gas-station-heroin-tianeptine-addiction.html?smid=url-share"},{"issue":"4","key":"1053_CR3","first-page":"89","volume":"73","author":"CJ Counts","year":"2024","unstructured":"Counts CJ, Spadaro AV, Cerbini TA, Krotulski AJ, Greller HA, Nelson LS, Ruck BE, Calello DP. Notes from the field: Cluster of severe illness from neptune\u2019s fix tianeptine linked to synthetic cannabinoids \u2014 New Jersey, June\u2013November 2023. MMWR. 2024;73(4):89\u201390.","journal-title":"MMWR"},{"issue":"7","key":"1053_CR4","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1038\/tp.2014.30","volume":"4","author":"MM Gassaway","year":"2014","unstructured":"Gassaway MM, Rives ML, Kruegel AC, Javitch JA, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a \u00b5-opioid receptor agonist. Transl Psychiatry. 2014;4(7):e411.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"1053_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/mp.2009.80","volume":"15","author":"BS McEwen","year":"2010","unstructured":"McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E. The neurobiological properties of tianeptine (Stablon): From monoamine hypothesis to glutamatergic modulation. Mol Psychiatry. 2010;15(3):237\u201349.","journal-title":"Mol Psychiatry"},{"key":"1053_CR6","doi-asserted-by":"publisher","first-page":"1186397","DOI":"10.3389\/fpsyt.2023.1186397","volume":"14","author":"F Allain","year":"2023","unstructured":"Allain F, Ehrlich AT, Gross MMF, Ma W, Kieffer BL, Darcq E. Chronic tianeptine induces tolerance in analgesia and hyperlocomotion via mu-opioid receptor activation in mice. Front Psychiatry. 2023;14:1186397.","journal-title":"Front Psychiatry"},{"issue":"5","key":"1053_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s40122-023-00539-5","volume":"12","author":"AN Edinoff","year":"2023","unstructured":"Edinoff AN, Sall S, Beckman SP, Koepnick AD, Gold LC, Jackson ED, Wenger DM, Cornett EM, Murnane KS, Kaye AM, Kaye AD. Tianeptine, an antidepressant with opioid agonist effects: Pharmacology and abuse potential, a narrative review. Pain Therapy. 2023;12(5):1121\u201334.","journal-title":"Pain Therapy"},{"issue":"30","key":"1053_CR8","first-page":"815","volume":"67","author":"T El Zahran","year":"2018","unstructured":"El Zahran T, Schier J, Glidden E, Kieszak S, Law R, Bottei E, Aaron C, King A, Chang A. Characteristics of tianeptine exposures reported to the National Poison Data System \u2014 United States, 2000\u20132017. MMWR. 2018;67(30):815\u20138.","journal-title":"MMWR"},{"key":"1053_CR9","unstructured":"U.S. Food and Drug Administration. Tianeptine products linked to serious harm, overdoses, death. [Internet]. U.S. Food and Drug Administration; 2022 [cited 2024 Jan 14]. https:\/\/www.fda.gov\/consumers\/consumer-updates\/tianeptine-products-linked-serious-harm-overdoses-death"},{"issue":"4","key":"1053_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/00952990.2021.1904408","volume":"47","author":"KE Smith","year":"2021","unstructured":"Smith KE, Rogers JM, Strickland JC, Epstein DH. When an obscurity becomes trend: Social-media descriptions of tianeptine use and associated atypical drug use. Am J Drug Alcohol Abuse. 2021;47(4):455\u201366.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1053_CR11","unstructured":"Food US, Administration D. Questions and answers on dietary supplements [Internet]. U.S. Food and Drug Administration; 2024 [cited 2024 Oct 24]. https:\/\/www.fda.gov\/food\/information-consumers-using-dietary-supplements\/questions-and-answers-dietary-supplements"},{"issue":"3","key":"1053_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/nutraceuticals3030034","volume":"3","author":"JT Seale","year":"2023","unstructured":"Seale JT, Garden EA, French JMT, McDougal OM. Analysis of tianeptine in dietary supplements. Nutraceuticals. 2023;3(3):481\u20138.","journal-title":"Nutraceuticals"},{"issue":"7","key":"1053_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jat\/bky023","volume":"42","author":"EL Bakota","year":"2018","unstructured":"Bakota EL, Samms WC, Gray TR, Oleske DA, Hines MO. Case reports of fatalities involving tianeptine in the United States. J Anal Toxicol. 2018;42(7):503\u20139.","journal-title":"J Anal Toxicol"},{"issue":"2","key":"1053_CR14","first-page":"e55120","volume":"16","author":"ED Espiridion","year":"2024","unstructured":"Espiridion ED, Qutob M, Lozano P. A case of \u2018Neptune\u2019s Fix Elixir\u2019: The dangerous consequences of unregulated use of tianeptine in over-the-counter products. Cureus. 2024;16(2):e55120.","journal-title":"Cureus"},{"issue":"6","key":"1053_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.psym.2018.07.006","volume":"59","author":"R Lauhan","year":"2018","unstructured":"Lauhan R, Hsu A, Alam A, Beizai K. Tianeptine abuse and dependence: Case report and literature review. Psychosomatics. 2018;59(6):547\u201353.","journal-title":"Psychosomatics"},{"key":"1053_CR16","unstructured":"Food US, Administration D. FDA warns consumers not to purchase or use neptune\u2019s fix or any tianeptine product due to serious risks. [Internet]. U.S. Food and Drug Administration; 2023 [cited 2024 Jan 14]. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-consumers-not-purchase-or-use-neptunes-fix-or-any-tianeptine-product-due-serious-risks"},{"key":"1053_CR17","unstructured":"Food US, Administration D. Urgent message from the U.S. Food and Drug Administration - Recalled neptune\u2019s fix products [Internet]. U.S. Food and Drug Administration; 2024 [cited 2024 Aug 22]. https:\/\/www.fda.gov\/files\/for%20consumers\/published\/urgent_message_from_us_fda_neptunes_fix_recall_01.31.2024.pdf"},{"key":"1053_CR18","unstructured":"U.S. Food and Drug Administration. Warning Letter to Premier Manufacturing Products, LLC. [Internet]. U.S. Food and Drug Administration; 2024 [cited 2024 Aug 5]. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/premier-manufacturing-products-llc-678912-07022024"},{"key":"1053_CR19","unstructured":"Food US, Administration D. Warning Letter to Crystal Clear Supplements. [Internet]. U.S. Food and Drug Administration; 2022 [cited 2024 Aug 5]. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/crystal-clear-supplements-620285-02042022"},{"key":"1053_CR20","unstructured":"U.S. Food and Drug Administration. To whom it may concern [Internet]. U.S. Food and Drug Administration; 2024 [cited 2024 Aug 22]. https:\/\/www.fda.gov\/media\/175628\/download"},{"issue":"11","key":"1053_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/15563650.2018.1476694","volume":"56","author":"JM Marraffa","year":"2018","unstructured":"Marraffa JM, Stork CM, Hoffman RS, Su MK. Poison control center experience with tianeptine: an unregulated pharmaceutical product with potential for abuse. Clin Tox. 2018;56(11):1155\u20138.","journal-title":"Clin Tox"},{"issue":"2","key":"1053_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/15563650.2020.1781151","volume":"59","author":"W Rushton","year":"2020","unstructured":"Rushton W, Whitworth B, Brown J, Kurz M, Rivera J. Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health. Clin Tox. 2020;59(2):152\u20137.","journal-title":"Clin Tox"},{"issue":"1","key":"1053_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5055\/jom.0851","volume":"20","author":"V Velagapudi","year":"2024","unstructured":"Velagapudi V, Calabrese J, Sethi R. Tianeptine as an opiate replacement in a patient on methadone treatment: A case report. J Opioid Manag. 2024;20(1):87\u201391.","journal-title":"J Opioid Manag"},{"key":"1053_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.toxrep.2023.07.006","volume":"11","author":"H Galust","year":"2023","unstructured":"Galust H, Seltzer JA, Hardin JR, Friedman NA, Minns A. Tianeptine abuse via novel, extended-release, star-shaped, drug delivery device. Toxicol Rep. 2023;11:162\u20134.","journal-title":"Toxicol Rep"},{"issue":"4","key":"1053_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/ADM.0000000000000490","volume":"13","author":"P Trowbridge","year":"2019","unstructured":"Trowbridge P, Walley AY. Use of buprenorphine-naloxone in the treatment of tianeptine use disorder. J Addict Med. 2019;13(4):331\u20133.","journal-title":"J Addict Med"},{"key":"1053_CR26","doi-asserted-by":"crossref","unstructured":"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2022 Annual report of the National Poison Data System (NPDS) from America\u2019s Poison Centers: 40th annual report. Clin Tox. 2023;61(10):717\u2013939.","DOI":"10.1080\/15563650.2023.2268981"},{"issue":"10","key":"1053_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.2105\/AJPH.2020.305842","volume":"110","author":"JE Carpenter","year":"2020","unstructured":"Carpenter JE, Chang AS, Bronstein AC, Thomas RG, Law RK. Identifying incidents of public health significance using the National Poison Data System, 2013\u20132018. Am J Public Health. 2020;110(10):1528\u201331.","journal-title":"Am J Public Health"},{"key":"#cr-split#-1053_CR28.1","unstructured":"U.S. Census Bureau Population Division. Annual estimates of the resident population by single year of age and sex for the United States: April 1, 2020 to July 1, 2023. [Internet]. U.S. Census Bureau"},{"key":"#cr-split#-1053_CR28.2","unstructured":"[cited 2024 Jun 20]. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2020s-national-detail.html"},{"key":"#cr-split#-1053_CR29.1","unstructured":"U.S. Census Bureau Population Division. Annual estimates of the resident population by single year of age and sex for the United States: April 1, 2010 to July 1, 2020. [Internet]. U.S. Census Bureau"},{"key":"#cr-split#-1053_CR29.2","unstructured":"[cited 2024 Jun 20]. https:\/\/www.census.gov\/programs-surveys\/popest\/technical-documentation\/research\/evaluation-estimates\/2020-evaluation-estimates\/2010s-national-detail.html"},{"key":"#cr-split#-1053_CR30.1","unstructured":"U.S. Census Bureau Population Division. Annual estimates of the resident population for the United States, regions, states, and Puerto Rico: April 1, 2010 to July 1, 2019. [Internet]. U.S. Census Bureau"},{"key":"#cr-split#-1053_CR30.2","unstructured":"[cited 2024 Jun 23]. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2010s-state-total.html"},{"key":"#cr-split#-1053_CR31.1","unstructured":"U.S. Census Bureau Population Division. Annual estimates of the resident population for the United States, regions, states, District of Columbia, and Puerto Rico: April 1, 2020 to July 1, 2023. [Internet]. U.S. Census Bureau"},{"key":"#cr-split#-1053_CR31.2","unstructured":"[cited 2024 Jun 23]. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2020s-state-total.html"},{"key":"1053_CR32","unstructured":"America\u2019s Poison Centers. National Poison Data System. NPDS coding user\u2019s manual [Internet]. America\u2019s Poison Centers; 2023 [cited 2024 Jun 20]. https:\/\/www.npds.us\/Help\/NPDS%20Coding%20User%20Manual%20(June%202023).pdf"},{"key":"1053_CR33","unstructured":"U.S. Census Bureau Geography Division. Census regions and divisions of the United States. [Internet]. U.S. Census Bureau; [cited 2024 Jun 20]. https:\/\/www.census.gov\/programs-surveys\/economic-census\/guidance-geographies\/levels.html#par_textimage_34"},{"issue":"2","key":"1053_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5455\/bcp.20130426010958","volume":"23","author":"N Durmus","year":"2016","unstructured":"Durmus N, Ozbilen G, Kasap Y, Koyuncu O, Yildirim O, Artiran G, Kerman S, Aydinkarahaliloglu D. Risk management in tianeptine abuse in Turkey: A national experience. Bull Clin Psychopharmacol. 2016;23(2):149\u201354.","journal-title":"Bull Clin Psychopharmacol"},{"key":"1053_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.forsciint.2007.03.035","volume":"170","author":"P Proen\u00e7a","year":"2007","unstructured":"Proen\u00e7a P, Teixeira H, Pinheiro J, Monsanto PV, Vieira DN. Fatal intoxication with tianeptine (Stablon). Forensic Sci Int. 2007;170:200\u20133.","journal-title":"Forensic Sci Int"},{"issue":"1","key":"1053_CR36","doi-asserted-by":"publisher","first-page":"e20151414","DOI":"10.1542\/peds.2015-1414","volume":"137","author":"C Bence","year":"2016","unstructured":"Bence C, Bonord A, Rebillard C, Vaast P, Alexandre C, Jardri R, Rolland B. Neonatal abstinence syndrome following tianeptine dependence during pregnancy. Pediatrics. 2016;137(1):e20151414.","journal-title":"Pediatrics"},{"issue":"6","key":"1053_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jat\/bkx034","volume":"41","author":"SK Dempsey","year":"2017","unstructured":"Dempsey SK, Poklis JL, Sweat K, Cumpston K, Wolf CE. Acute toxicity from intravenous use of the tricyclic antidepressant tianeptine. J Anal Toxicol. 2017;41(6):547\u201350.","journal-title":"J Anal Toxicol"},{"issue":"9","key":"1053_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/0960327110372403","volume":"29","author":"M Ari","year":"2010","unstructured":"Ari M, Oktar S, Duru M. Amitriptyline and tianeptine poisoning treated by naloxone. Hum Exp Toxicol. 2010;29(9):793\u20135.","journal-title":"Hum Exp Toxicol"},{"key":"1053_CR39","unstructured":"Alabama House Bill 2. Controlled substances, tianeptine and related compounds [Internet]. Alabama House Bill 2; 2021 [cited 2024 Aug 22]. https:\/\/www.billsponsor.com\/bills\/39116\/alabama-house-bill-2-session-2021rs"},{"key":"1053_CR40","unstructured":"Alabama Uniform Controlled Substances Act, Title C. 2, Article 2, Sects. 20-2-23, Schedule 1 - Listing of Controlled Substances [Internet]. Alabama Uniform Controlled Substances Act; 2023 [cited 2024 Aug 22]. https:\/\/law.justia.com\/codes\/alabama\/title-20\/chapter-2\/article-2\/section-20-2-23\/"},{"key":"1053_CR41","doi-asserted-by":"publisher","first-page":"100272","DOI":"10.1016\/j.dadr.2024.100272","volume":"12","author":"HL Hershey","year":"2024","unstructured":"Hershey HL, Onyango EM, Durst K, Korona-Bailey J, Mukhopadhyay S. Tianeptine-involved emergency department visits, fatal overdoses, and substance seizures in Tennessee, 2021\u20132023. Drug Alcohol Depend Rep. 2024;12:100272.","journal-title":"Drug Alcohol Depend Rep"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-024-01053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-024-01053-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-024-01053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:05:47Z","timestamp":1736273147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-024-01053-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s13181-024-01053-6","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest nor financial disclosures relevant to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous Presentation of Data"}}]}}